Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04753385 · ClinicalTrials.gov registry record
The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
A clinical trial, sponsored by LivaNova.
- Terminated
- Registry status
- 138
- Enrollment target
NCT04753385 is a clinical trial that was terminated before completion, run by LivaNova. The registered enrollment target is 138 participants.
The verdict
NCT04753385 was terminated before completion, sponsored by LivaNova.
- TERMINATED
- Registry status
- 138 participants
- Enrollment target
Study Summary
The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2024-09-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04753385
The ClinicalTrials.gov registry entry for NCT04753385 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LivaNova, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04753385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04753385 about?
NCT04753385 is a clinical study titled "The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes". The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomi...
What is the current status of trial NCT04753385?
This trial is currently terminated. The enrollment target is 138 participants. The study started on 2021-03-23. Estimated completion is 2024-09-06.
Who is sponsoring clinical trial NCT04753385?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.